Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Tokyo - Delayed Quote JPY

Eiken Chemical Co., Ltd. (4549.T)

2,234.00
+18.00
+(0.81%)
At close: April 28 at 3:30:00 PM GMT+9

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in JPY.
NameTitlePayExercisedYear Born
Mr. Tsugunori Notomi President, CEO & Director -- -- 1958
Mr. Hajime Watari Senior VP, Executive Officer, GM of Corporate Administration & Director -- -- 1960
Mr. Yuji Segawa Executive Officer and GM of Marketing & Sales -- -- 1965
Mr. Shinya Sadamoto Executive Officer & GM of Internal Audit Office -- -- 1961
Mr. Naomichi Harada VP, Executive Officer & GM of Sales Division -- -- 1960
Mr. Hidetoshi Kanda VP, Executive Officer, GM of R&D Division and Fundamental Research Laboratory -- -- 1960
Mr. Testuya Takahashi Executive Officer and General Manager of Sales Promotion Office & Sales Division -- -- 1963
Mr. Michitoshi Doi Exe. off, GM of Production Mgt Dept, GM of Production Control Offiand GM of Quality Assurance Office -- -- 1961
Yasuyoshi Mori Executive Officer and GM of Overseas Planning, Sales Office & Sales Division -- -- 1967
Mr. Hiroyasu Furuhashi Executive Officer and GM of Nogi Plant & Production Division -- -- 1963

Eiken Chemical Co., Ltd.

4-19-9 Taito
Taito-ku
Tokyo, 110-8408
Japan
81 3 5846 3305 https://www.eiken.co.jp
Sector: 
Healthcare
Industry: 
Medical Devices
Full Time Employees: 
757

Description

Eiken Chemical Co., Ltd. engages in the manufacturing and sale of clinical diagnostics in Japan. It offers microbiological reagents for diagnosis of microorganism infection, such as mediums, antimicrobial susceptibility, and rapid test reagents; urinalysis test strips for occult blood, protein, and glucose; and fecal immunochemical tests reagents for screening of colorectal cancer. The company also provides immunological and serological reagents to detect and monitor infectious disease, rheumatism, inflammation, atrophic gastritis, and prostate specific antigens; and clinical chemistry tests to measure and analyze biological components in blood serum and urine. In addition, it sells reagents and devices of microbiological test for food poisoning bacteria and environmental inspection; and offers nucleic acid amplification method, as well as provides various types of automated analyzers. The company was formerly known as Nihon Eiyokagaku Co., Ltd. and changed its name to Eiken Chemical Co., Ltd. in 1969. Eiken Chemical Co., Ltd. was incorporated in 1939 and is headquartered in Tokyo, Japan.

Corporate Governance

Eiken Chemical Co., Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

May 13, 2025 at 6:00 AM UTC

Eiken Chemical Co., Ltd. Earnings Date

Recent Events

March 28, 2025 at 12:00 AM UTC

Ex-Dividend Date